A Study of Surgical Wound Infection in Government Rajaji Hospital, Madurai by Kannaki, R
A STUDY OF SURGICAL WOUND INFECTION IN 
GOVERNMENT RAJAJI HOSPITAL, MADURAI 
DISSERTATION SUBMITTED FOR
BRANCH - I  M.S (GENERAL SURGERY)
MARCH  2009
THE TAMILNADU 
DR.M.G.R.MEDICAL UNIVERSITY 
CHENNAI 
BONAFIDE CERTIFICATE
This is to certify that the dissertation entitled “A STUDY OF SURGICAL 
WOUND  INFECTION  IN  GOVT.  RAJAJI  HOSPITAL,  MADURAI” 
submitted  by  Dr.  R.  KANNAKI  to  the  Tamil  Nadu  Dr.  M.G.R.  Medical 
University, Chennai in partial fulfillment of the requirement for the award of M.S 
Degree Branch –I (General Surgery) is a bonafide research work were carried out 
by her under direct supervision & guidance.
Prof.Dr.S.M. Sivakumar, M.S.,       Prof.Dr.M.Gopinath, M.S.,
Unit Chief, Head of the Department,
Department of Surgery, Department of Surgery,
Madurai Medical College,       Madurai Medical College,
Madurai. Madurai.
Prof.Dr.S.M. Sivakumar, M.S.,
The Dean,
Madurai Medical College,
Govt. Rajaji Hospital,
Madurai Medical College,       
Madurai.
DECLARATION
I  Dr.   R.  KANNAKI  declare  that,  I  carried  out  this  work  on,  “A 
STUDY  OF  SURGICAL  WOUND  INFECTION  IN  GOVT.  RAJAJI 
HOSPITAL, MADURAI” at the Department of Surgery, Govt. Rajaji Hospital 
during the period of June 2006 to June 2008.  I also declare that this bonafide work 
or a  part  of  this  work was not  submitted by me or any others  for  any award, 
degree, diploma to any other University, Board either in India or abroad.
This  is  submitted  to  The  Tamilnadu  Dr.  M.  G.  R.  Medical  University, 
Chennai  in  partial  fulfillment  of  the  rules  and  regulations  for  the  M.S degree 
examination in General Surgery.
Place  : Madurai      Dr. R. KANNAKI
Date   :
ACKNOWLEDGEMENT
I  wish  to  express  my  sincere  gratitude  to  my  Chief 
Prof.Dr.S.M.Sivakumar,  M.S.,  Additional  Professor  of  Surgery,  Madurai 
Medical  College,  Madurai  for  his  excellent  guidance  in  making  this  study, 
inspiration and encouragement he rendered at every stage of this study, without 
which this dissertation would not have been possible.
My sincere thanks to  Prof.Dr.M.Gopinath. M.S.,  FRCS, Professor and 
Head of the Department of Surgery, for his able guidance in doing this project.
My  profound  thanks  to  Dr.  S.M.  Sivakumar,M.S.,  Dean,  Government 
Rajaji Hospital, Madurai Medical College, Madurai for permitting me to utilise the 
clinical materials of the hospital.
I thank the Department of Microbiology for their help and guidance in this 
study.
I also thank my Assistant Professors  Dr. S.R.Dhamodaran, M.S., Dr. P. 
Amutha M.S.,  Dr. Lakshmi Narayanan, M.S., Dr. M. Manikandan, M.S., for 
their valuable guidance.
I also wish to record my deep sense of appreciation and gratitude to the 
patients who have co-operated with enthusiasm and rendered themselves for this 
study.
                                    CONTENTS
S.No. Title Page
1. Introduction 1
2. Aim of Study 4
3. Materials and Methods 5
4. Terminology  and  Definitions  of  Surgical  Site 
Infection
6
5. Epidemiology and Risk factors for Surgical Site 
Infection
12
6. Microbiology 18
7. Role of pre-operative preparation 20
8. Role of pre-operative antibiotics 25
9. Role of post operative care 31
10. Cellular,  Biochemical,  Clinical  pathological 
aspects of wound healing
35
11 Observation and Results 48
12. Discussion 50
13. Conclusion 53
14. Bibliography
15. Proforma
16. Master Chart
INTRODUCTION
Hundreds of Millions of People around the world undergo surgery each 
year.  Infection of the surgical site (formerly referred to as ‘wound infection’, 
terminology that is no longer used owing to confusion between infections of 
surgical  incisions  and  those  of  traumatic  wounds)  is  a  consequence  of 
surgery, but it is not inevitable.  Surgical site infection (SSI) entirely the fault 
of the operating surgeon, despite the contrary belief of many members of the 
quality improvement bureaucracy.  This review will examine the factors that 
increase  the  risk  of  surgical  site  infection,  and  interventions  that  can 
decrease the incidence of infection.
Surgical site infection is most challenging to every surgeons and each 
and every body is trying their methods to reduce the problem.
Before the mid-19th century, surgical patients commonly developed post 
operative ‘incapacitating fever’, followed by purulent discharge at the site of 
surgical incision followed by overwhelming sepsis, and often death would 
result.   It  was not  until  the late  1860s,  after  Joseph Lister  introduced the 
principles  of  antisepsis,  the  postoperative  infection  associated  morbidity 
decreased substantially.  There was a radical change in surgery after Lister’s 
pioneering  work  which  resulted  in  shift  in  the  surgical  outcome  from 
infection, high morbidity and mortality to a procedure that could eliminate 
suffering and prolong life.
The centers for Disease Control and Prevention (CDC) and National 
Nosocomial  Infections  Surveillance  (NNIS)  system,  established  1970, 
monitors reported trends in nosocomial infections in US acute care hospitals. 
Based on NNIS system reports, Surgical Site Infections (SSIs) are the third 
most  frequently  reported  nosocomial  infection,  accounting  for  14  to  16 
percent of all nosocomial infections among hospitalized patients.
Among surgical patients, surgical site infections were the most common 
nosocomial infection, accounting for 38 percent of all such infections.  Of 
these surgical site infections two third were confined to the incision, and one 
third  involved  organs  or  spaces  accessed  during  surgery.   When  surgical 
patients  with  nosocomial  SSI  died,  77 percent  of  the  deaths  were  due to 
infection and the majority (93%) were serious infections involving organs or 
spaces accessed during the operation.
Advances  in  infection  control  practices  include  improved  operating 
room  ventilation,  sterilization  methods,  barriers,  surgical  technique,  and 
availability  of  antimicrobial  prophylaxis.   Despite  these  activities,  SSIs 
remain a  substantial  cause of  morbidity  and mortality  among hospitalized 
patients.  There also are increased numbers of prosthetic implant and organ 
transplant operations performed.   Thus,  to reduce the risk of  surgical  site 
infection,  a  systemic  but  realistic  approach  must  be  applied  with  the 
awareness  that  this  risk  is  influenced  by  characteristics  of  the  patient, 
operation, personnel and hospital. Paramount significance need be given to 
all  the  equipment  that  is  used  on  the  patient  rather  than  the  inanimate 
environment of air quality.  This implies that monitoring of Central sterile 
service departments (CSSD) is a necessity for the success of a procedure.
AIM OF STUDY
• Surgical  site  infection is  most  challenging to  every  surgeons  and 
each  and  every  one  is  trying  their  own  methods  to  reduce  the 
problem
• So our aim is also to try new modalities to reduce the surgical site 
infection
MATERIALS AND METHODS
• We  tried  4%  chlorhexidine  gluconate  for  topical  antiseptic  at  site 
instead of povidone Iodine.
• Using Hair clippers instead of pre operative saving
• Insisting  the  use  of  cap  and  mask  by  all  medical  and  paramedical 
personals inside the operation theatre.
Method :
The patients are instructed to take bath with ordinary antiseptic soap in 
the previous evening and the morning on the day of surgery.
At the operation site the skin is prepared immediately before surgery by 
removing the hair  by clipping and thorough washing done with antiseptic 
soap.
On  the  table  before  drapping  the  operation  site  painted  with  4% 
chlorhexidine antiseptic solution and allowed to dry.
All personals inside the theatre are instructed strictly to wear cap and 
mask and separate theatre dress.
Microbiology swab sent for every infected cases for culture and sensitivity.
TERMINOLOGY AND DEFINITIONS OF 
SURGICAL SITE INFECTION
What constitutes a Surgical site infection ?  There is little agreement on 
the matter with respect to the appearance of the incision, even among experts. 
Is it cellulites of the incision without drainage or, alternatively, non-purulent 
drainage without cellulites? Is any incision infected that must be reopened, or 
is the requirement for antimicrobial therapy the best indicator?  Most experts 
agree that surgical sites that do not harbor purulent fluid are not infected, but 
the  lack  of  agreement  otherwise  means  that  any  retrospective  study  of 
surgical site infection is essentially unreliable, and useless if it relied upon 
observation or antibiotic  administration as diagnostic criteria.   Prospective 
studies must ensure that criteria for the appearance of the incision are explicit 
before the study starts, that all observers have been trained, and that inter-
rater reliability is high.
Infection may occur within the surgical site at any depth, from the skin 
itself  to the depths of the cavity  that  remains after  resection of an organ. 
Superficial SSI involves tissues down to the fascia, whereas deep SSI extends 
beneath the fascia but not intracavitary.  Infection of a visceral cavity (eg. 
Intra-abdominal abscess following intestinal surgery) is referred  to as organ / 
space infection).
Centers  for  Disease  Control  and  Prevention  (CDC)  Definitions  for 
Surgical Site Infection (SSI)
Superficial incisional S  urgical site infection  
Infection occurs within 30 days after  the operation and infection involves 
only skin or subcutaneous tissue of the incision and
At least one of the following :
1. Purulent drainage,  with or without laboratory confirmation,  from the 
superficial incision
2. Organisms  isolated  from an  aseptically  obtained  culture  or  fluid  or 
tissue from the superficial incision.
3. Atleast one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat, and superficial incision 
is  opened deliberately by the surgeon,  unless the incision is  culture-
negative. 
4. Diagnosis  of  superficial  incisional  surgical  site  infection by  the 
surgeon
Deep incisional  Surgical site infection :  Infection occurs within 30 days 
after the operation if no implant is in place, or within 1 year if implant is in 
place, and the infection appears to be related to the operation and Infection 
involves deep soft tissue (eg. Fascial and muscle layers) of the incision and
Atleast one of the following
1. Purulent drainage from the deep incision but not from the organ / space 
component of the surgical site.
2. A deep incision dehisces spontaneously or is opened deliberately by a 
surgeon when the  patient  has  at  least  one of  the  following signs  or 
symptoms: Fever (> 38C), localized pain, or tenderness, unless site is 
culture negative.
3. An abscess or other evidence of infection involving the deep incision is 
found on direct examination, during reoperation, or by histopathologic 
or radiologic examination.
4. Diagnosis of a deep incisional surgical site infection by the surgeon.
Organ / Space SSI
Infection occurs within 30 days after the operation if no impact is left in 
place or within 1 year if implant is in place and the infection appears to be 
related to the operation. And
Infection involves any part of the anatomy (eg. Organs or spaces) other 
than the incision, which was opened or manipulated during an operation. 
And
Atleast one of the following :
1. Purulent drainage from a drain that is placed through a stab wound into 
the organ / space
2. Organisms  isolated  from an  aseptically  obtained  culture  of  fluid  or 
tissue in the organ / space
3. An abscess or other evidence of infection involving the organ / space 
that  is  found  on  direct  examination,  during  reoperation,  or  by 
histopathologic or radiologic examination.
4. Diagnosis of an organ / space surgical site infection by the surgeon.
The degree of bacterial contamination of the surgical site has been well 
defined. Clean surgical procedures are those where the operation has affected 
only  integumentary  and musculoskeletal  soft  tissues.   Clean-contaminated 
procedures  are  those  where  a  hollow  viscus  (eg.  Alimentary,  biliary, 
genitourinary, respiratory tract) has been extensive introduction of bacteria 
into a normally sterile body cavity, but for a period of time too brief to allow 
infection to become established during surgery (eg. Penetrating abdominal 
trauma, enterotomy during adhesiolysis for mechanical bowel obstruction). 
Dirty  procedures  are  those  where  the  surgery  is  performed  to  control 
established infection (eg. Colon resection for complicated diverticulitis).
Cellulitis refers to infection related erythema of skin (although other 
tissues may be affected) without drainage or fluctuance.  Abscess refers to 
localized  collections  of  purulent  material  within  tissue.   Necrotizing  soft 
tissue infections (NSTI) invade tissue necrosis. When fascial is involved the 
infection is referred to correctly as necrotizing fascitis ; myonecrosis refers to 
involvement  of  underlying  muscle.   Necrotizing  soft  tissue  infections  are 
usually  community  acquired  infections  that  require  aggressive  surgical 
debridement in addition to antibiotic therapy, and further discussion herein is 
not germane.  Most SSIs do not cause extensive tissue necrosis, especially if 
the  gastrointestinal  tract  has  not  been  entered  during  surgery.  Rare  but 
dangerous  exceptions  to  that  rule  are  SSIs  caused  by  Streptococcus 
pneumoniae Clostridium perfringens.
EPIDEMIOLOGY AND RISK FACTORS FOR 
SURGICAL SITE INFECTION
Numerous  factors  determine  whether  a  patient  will  develop  a  SSI 
including  factors  contributed  by  the  patient,  the  environment  and  the 
treatment.  According  to  the  National  Nasocomal  infection  surveillance 
(NNIS)  classification,  the  risk  of  surgical  site  infection  increases  with  an 
increasing number of risk factors present, irrespective of the contamination of 
the incision and almost without regard for the type of operation.
Laproscopic surgery  is  associated with a decreased incidence of SSI 
under  certain  circumstances,  which  has  required  a  modification  of  the 
National  Nasocomal  infection  surveillance  risk  classification.   For 
laparoscopic biliary, gastric, and colon surgery, one risk factor is subtracted if 
the operation is performed via the laparoscope – a new category has been 
created specifically for the circumstance, representing, essentially, - 1 risk 
factor.  The reasons that laparoscopic surgery decreases the risk of SSI are 
potentially several, including decreased wound size, limited use of cautery in 
the  abdominal  wall,  or  a  diminished  stress  response  to  tissue  injury. 
Laparoscopic appendectomy, on the other hand, is  a unique circumstance. 
When no risk factors are present, the incidence of surgical site infection after 
laparoscopic appendectomy is reduced significantly, but if any risk factors is 
present  (as  would  be  the  case  with  either  perforated  appendicitis  or  a 
procedure that last longer than 1h), then the advantage is lost.
More  than  70%  of  surgical  procedures  are  now  performed  on  an 
outpatient  basis,  which  poses  major  problems  for  surveillance  of  SSI. 
Although many surgical site infections will develop in the 5-10 days after 
surgery,  a  SSI  will  develop  as  long  as  30  days  after  surgery  and  be 
attributable directly  to the operation,  long after  even most inpatients have 
been discharged from the hospital.  Estimates of the incidence of surgical site 
infections  are  thus  dependent  upon  voluntary  self  reporting  by  surgeons, 
which may not occur for any of several reasons.  Therefore, estimates of the 
incidence  of  surgical  site  infection  in  National  Nasocomal  infection 
surveillance are almost assuredly underestimates, although the data are the 
best that are available.
Host-derived  factors  may  contribute  importantly  to  the  risk  of  SSI. 
Factors of importance include increased age, obesity, malnutrition, diabetes 
mellitus,  hypocholesterolemia  and  numerous  other  factors  that  are  not 
accounted for specifically by the National Nasocomal infection surveillance 
(NNIS) system.  
In one study of 2345 patients undergoing cardiac surgery, the overall 
incidence of SSI was 8.5% (199/2345). The relative risk for the development 
of SSI among diabetic patients was 2.29 (95% CI 1.15-4.54), and the relative 
risk  among obese patients  (body  mass  index > 30)  was 1.78 (1.24-2.55). 
Malone et al, studied 5,031 patients who underwent noncardiac surgery at a 
Veterans Affairs hospital over a six year period ending in 1990.  The overall 
incidence of SSI was 3.2% and independent risk factors for the development 
of  infection  included  ascites,  diabetes  mellitus,  postoperative  anemia,  and 
recent weight loss, but not chronic obstructive pulmonary disease, tobacco 
use or corticosteroid use.  In a prospective study of 9,016 patients, 12.5% of 
patients  developed a  postoperative  infection of  some type within  28 days 
after surgery.  The likelihood of readmission for infection management and 
of death were both 2.5% within the period. Multivariate analysis revealed 
that  decreased serum albumin concentration,  increased  age,  tracheostomy, 
and amputations were associated with an increased probability of an early 
infection,  whereas  factors  associated  with  readmission  due  to  infection 
included  dialysis  shunt,  vascular  repair,  and  an  early  infection.   Factors 
associated with 28 day mortality included increased age, low serum albumin 
concentration,  increased  serum  creatinine  concentration,  and  an  early 
infection.
RISK FACTORS FOR THE DEVELOPMENT OF SURGICAL SITE 
INFECTION
1. Environmental factors
Contaminated medications
Inadequate disinfection / sterilization
Inadequate skin antisepsis
Inadequate ventilation
2. Patient Factors
Ascites
Chronic inflammation
Corticosteroid therapy (controversial)
Obesity
Diabetes
Extremes of age
Hypocholesterolemia
Hypoxemia
Peripheral vascular disease (especially for lower extremely surgery)
Postoperative anemia
Prior site irradiation
Recent operation
Remote infection
Skin carriage of staphylococci
Skin disease in the area of infection (eg. Psoriasis)
Under-nutrition
Treatment factors
Drains
Emergency procedure
Hypothermia
Inadequate antibiotic prophylaxis
Oxygenation
Prolonged preoperative hospitalization
Prolonged operative time.
MICROBIOLOGY
Inoculation  of  the  surgical  site  occurs  during  surgery,  either  inward 
from the skin or out-ward from the internal organ being operated on, hence 
the rationale for skin preparation and bowel preparation with antiseptics or 
antibiotics,  and prophylactic  oral  or parenteral  administration of antibiotic 
prophylaxis.  The microbiology of surgical site infection depends on the type 
of  operation  being  performed,  with  an  increased  likelihood  of  infection 
caused  by  gram-negative  bacilli  after  gastrointestinal  surgery.   However, 
most  SSI  are  caused  by  gram  positive  cocci,  including  Staphylococcus 
aureus,  coagulase-negative  staphylococci  (usually  staphylococcus 
epidermidis), and Enterococcus sp., organisms that for the most part are skin-
derived.   With  surgery  of  the  head  and  neck  (when  pharyngoesophageal 
structures are entered) or intestinal surgery, enteric aerobic (eg. Escherichia 
coli)  and  anaerobic  (eg.  Bacteroides  fragilis)  bacteria  may  cause  SSI. 
Perioperative antibiotic prophylaxis decreases only the incidence of surgical 
site  infection,  not  that  of  other  nosocomial  infections.   Therefore,  for 
prophylaxis of most procedures where prophylaxis is indicated, an agent with 
activity  against  community  acquired  (ie.  methicillin  sensitive) 
Staphylococcus aureus is appropriate.
Microbiology of Surgical Site infection :
Pathogen Prevalence 
(%of isolates)
Staphylococcus 19
Coagulase-negative staphyloccus 14
Enterococcus sp. 12
Escherichia coli 8
Pseudomonas aeruginosa 8
Miscellaneous aerobic gram negative bacilli 7
Enterobacter sp 6
Streptococcus sp 6
Klebsiella sp 4
Miscellaneous anaerobic bacteria 3
Miscellaneous aerobic gram positive bacteria 2
ROLE OF PREOPERATIVE PREPARATION
Patient – Related :
Antiseptic baths preoperative bath / showers reduce the microbial load 
of the skin.  For this purpose chlorhexidine has been found to be more useful 
than povidine – iodine or triclocarbon medicated soap as it achieves a nine 
fold  reduction  in  microbial  load  as  compared  to  latter  which  achieve  a 
reduction  of  1  to  2  fold.   In  our  country,  where  poor hygienic  standards 
prevail,  this  practice  of  antiseptic  baths  preoperatively  needs  to  be 
encouraged.
Preoperative hair removal : 
Shaving  the  surgical  site  the  night  before  an  operation  results  in  a 
significant  risk  for  SSI  microscopic  cuts  serve  as  foci  for  bacterial 
multiplication.   Clipping  hair  immediately  before  an  operation  has  been 
associated with decreased rates of surgical site infections and hence is the 
recommended practice.  Shaving should be discouraged. 
Patient skin preparation in the operating room : 
 The  iodophors  (povidine  iodine  10%),  products  and  chlorhexidine 
gluconate 4 percent in alcohol are the most commonly used agents.  Alcohol 
has germicidal activity against bacterial, viruses and fungi, but spores can be 
resistant.  One major deterrent to the use of alcohol in the operating room is 
its  inflammability.   Chlorhexidine  gluconate  and  iodophores  have  broad 
spectra of antimicrobial activity, but the former has greater residual activity 
and is not activated by blood or serum proteins.  Prior to skin preparation, the 
skin  should  be  freed  of  gross  contamination.   Applying  antiseptic  in 
concentric  circles,  beginning  in  the  are  of  the  proposed  incision.   The 
prepared area should be large enough to extend the incision or create new 
incision or drain sites, if necessary.
The Operating Room environment :
Much of what is taken for granted in the modern operating room can, if 
lapses  occur,  result  in  increased  rates  of  SSI.   The  elements  of  proper 
operating room design, management, and comportment have been reviewed 
in an evidence – based manner.
Although such factors as proper sterilization technique and ventilation 
should not be the everyday concern of the surgeon, operating room personnel 
must  remain  vigilant.   The  surgeon  must  be  responsible  for  his  or  her 
personal hygiene (eg. Hand scrubbing, hair) and that of the team of assistants. 
Recent data indicate that a brief rinse with soap and water followed by use of 
an alcohol gel hand rub is equivalent to the prolonged (and ritualized) session 
at the scrub sink.
Careful  preparation  of  the  skin  with  an  appropriate  antiseptic  is 
essential.  There are no data to show that one method (eg. Alcohol based vs 
povidone-iodine) is superior to an other, and also no data to raise concerns 
about lack of efficacy of the new quick drying gel formulations.  However 
there are also no data to show that untreated or iodine impregnated adhesive 
plastic drapes reduce the risk of surgical site infection, so routine usage of 
such products may be foregone.
About 20% of surgical gloves fail during an operation, so there exists 
the  possibility  of  contamination  of  the  surgical  field  (as  well  as  contact 
between surgeon and the patient’s body fluids) ; therefore, attention must be 
paid  to  regular  inspection  of  gloves  during  a  procedure.  Likewise,  most 
surgical  gowns in use offer limited protection (1.5 – 2 h at most) against 
strike  through of  fluids.   It  may  be prudent  to  change gowns and gloves 
regularly (every 2h or so) during long procedures, and certainly if there is any 
evidence of loss if integrity of barrier materials.
Although  most  flora  that  pose  a  risk  of  infectivity  in  SSI  are  skin 
derived  and inoculated  during the  procedure,  airborne  bacteria,  especially 
staphylococci, do pose some risk.  Surgeons who are chronic nasal carriers of 
S.ureus have higher rates of SSI than do their non colonized brethren. It is 
recommended that surgical  masks should cover the mouth and nose at all 
times, and that unnecessary conversation at the operating table be kept to a 
minimum.
Patients  may  become  hypothermic  during  surgery  if  they  are  not 
warmed actively, owing to evaporative water losses, administration of room 
temperature fluids, and other factors.  There is no longer a question whether 
maintenance of normal core body temperature is important for decreasing the 
incidence  of  surgical  site  infection  ;  the  answer  is  unequivocally  yes. 
Following the seminal observation that  mild intraoperative hypothermia is 
associated with an increased rate of SSI following elective colon surgery, two 
other studies have provided corroboration.  In one randomized study, 30 min 
of  active  preoperative  warming reduced the  rate  of  surgical  site  infection 
following minor clean operations.
ROLE OF PREOPERATIVE ANTIBIOTICS
What is decisive period  :
The acute inflammatory, humoral and cellular process takes 4 hrs to 
mobilise body’s response to a breach in its defense.  This is called decisive 
period. And it is the time when the invading bacteria have a heard start in 
setting  established  in  the  tissues.  So  this  is  the  optimal  period  of  giving 
preoperative antibiotic.
The administration of antibiotics prior to surgery is common place and 
of  proven  benefit  in  many  circumstances  for  the  minimization  of  post 
operative surgical site infection.  However, it is only the surgical incision that 
is afforded protection and antibiotics are not a panacea.  If not administered 
properly, antibiotic prophylaxis will not be effective and may be harmful.
Some patients benefit from antibiotic prophylaxis whereas others may 
not.  An increased risk of surgical site infection occurs with an increasing 
degree of wound contamination (eg. Clean Vs contaminated) regardless of 
other risk factors and as the number of risk factors increases for a given type 
of operation.
Antibiotic prophylaxis of clean surgery is controversial.  Where bone is 
incised (eg. Craniotomy, sternotomy) or a prosthesis is inserted, antibiotic 
prophylaxis is generally indicated. The controversy exists in the case of clear 
surgery of soft tissues (eg. Breast hernia). A randomized prospective trial has 
shown some benefit of prophylaxis, but the results are confounded by higher 
than expected infection rates in the control group.) regardless of other risk 
factors  and  as  the  number  of  risk  factors  increases  for  a  given  type  of 
operation.
Which  antibiotic  should  be  chosen  from  the  plethora  of  available 
agents? Four principles should guide selection : The agent should be safe; the 
agent should have an appropriately narrow spectrum for coverage of relevant 
pathogens ; the agent should not be one that has a heavy reliance for clinical 
treatment of infection, owing to the possibility that resistance may develop if 
the agent is overused ; and the agent must be administered for a defined, brief 
period of time (certainly no more than 2 hrs).  Most surgical site infection s 
are  caused  by  gram  positive  cocci.   The  most  common  etiologic  agent 
causing  SSI  after  clean  surgery  is  staphylococcus  aureus,  followed  by  S. 
epidermidis. Enterococcus aecalis, Escherichia coli, and Bacterioides fragilis 
are  common pathogens  in  surgical  site  infection  after  clean-contaminated 
surgery.   The  antibiotic  chosen  should  be  directed  primarily  against 
staphylococci  for  clean  cases  and  high  risk  clean  contaminated  elective 
surgery of the biliary and upper gastrointestinal  tracts.   A first  generation 
cephalosporin  is  the  preferred  agent  for  most  patient,  with  a  history  of 
anaphylaxis to penicillin. Although methicillin resistant S. aureus  Methicillin 
Resistant S. aureus (MRSA) has been isolated in the community from never 
hospitalized  patients,  vancomycin  prophylaxis  is  appropriate  only  in 
institutions where the incidence of Methicillin Resistant  S. aureus (MRSA) 
is high.
When should parenteral antibiotics be given for optimum effect?  It is 
firmly established that the optimal time to give cephalosporin prophylaxis is 
within 2 hr prior to the time the incision is made. Antibiotics given sooner 
(except  possibly  for  longer  half  life  agents  such  as  quinolones  and 
metronidazole)  are  not  effective,  nor  are  agents  that  are  given  after  the 
incision is closed.  Antibiotics with short half lives should be re-dosed during 
surgery if the operation is prolonged or bloody and there is still some benefit 
if the initial antibiotic dose is given intraoperatively.
A simple way to organize antimicrobial prophylaxis (AMP) indications 
is based on using the surgical wound classification scheme as shown in table, 
which employs descriptive case features to post operatively grade the degree 
of intraoperative microbial contamination.  A surgeon makes the decision to 
use  antimicrobial  prophylaxis  (AMP)  by  anticipating  preoperatively  the 
surgical wound class for a given operation.
Surgical wound classification
Class I / Clean :  
An  uninfected  operative  wound  with  no  inflammation  and  the 
respiratory,  alimentary,  genital  or  uninfected  urinary  tract  not  entered,  in 
addition, clean wounds are primarily closed and if necessary, drained with 
closed drainage.   Operative incisional  wounds that  follow non-penetrating 
(blunt) traumas should be included in the category if they meet the criteria.
Class II / Clean-Contaminated :
An operative wound where respiratory, alimentary, genital, or urinary 
tracts  are  entered  under  controlled  conditions  and  without  unusual 
contamination.   Specially,  operations involving the biliary tract,  appendix, 
vagina, and oroharynx are included in this category, provided no evidence of 
infection or major break in technique is encountered.
Class III / contaminated :
Open,  fresh,  accidental  wounds,  in  addition,  operation  with  major 
breaks in sterile technique (eg. Open cardiac massage) or gross spillage from 
the  gastrointestinal  tract  and  incisions  in  which  acute,  non-purulent 
inflammation is encountered are included in this category.
Class IV / Dirty – infected :
Old traumatic wounds with retained devitailized tissue and evidence of 
clinical  infection  or  perforated  viscera.   This  identification  suggests  the 
organisms causing post operative infection were present in the operative field 
before the operation.
ROLE OF  POST OPERATIVE CARE
Blood transfusion 
In surgery and trauma, blood transfusions are given commonly and may 
be life-saving; alternatives to transfusions in the acute setting are few, but for 
hemodynamically  stable  postoperative  patients,  hemoglobin  concentrations 
of >7 g/ dL are well tolerated.  Erythropoietin administration may decrease 
transfusion  requirements  of  the"  chronically  critically  ill"  patient.  An 
expanding  body  of  evidence  suggests  that  blood  transfusion  should  be 
avoided, if possible.
Observations that blood transfusions are associated with increased rates 
of  nosocomial  infection  are  numerous.  Blood  transfusions  have  been 
associated  with  an  increased  risk  of   infection  following  penetrating 
abdominal trauma independent of related factors such as shock or acute blood 
loss  and  have  been,  related  to  increasing  injury  severity  and  increasing 
transfusion volume in unselected trauma patients.  Data suggest  that  blood 
transfusion therapy of 6-20 units in the 'first 12 h following multiple trauma 
is  associated  with  an  increased  risk  of  nosocomial  infection   The risk  of 
infection increased as the total transfusion volume increased, especially when 
units were transfused after more than 14 days of storage. 
The  postulated  "storage  lesion"  is  complex,  but  includes  changes  in 
oxygen affinity, red blood cell deformability, shortened circulation time, and 
the  biologic  consequences  of  cytokine  generation  and  release.  Recently, 
observational studies have suggested that transfusion of critically ill patients 
increases the risk of nosocomial infection may worsen Multi organ disease 
syndrome (MODS), and increases mortality.
Hyperglycemia, nutrition, and controlof blood sugar
Hyperglycemia  has  several  deleterious  effects  upon  host  immune 
function,  most  notably  impaired  function  of  neutrophils  and mononuclear 
phagocytes.  It  is  possible  also  that  hyperglycemia  is  a  marker  of  the 
catabolism and insulin resistance associated with the surgical stress response, 
and that exogenous insulin administration may ameliorate the catabolic state.
Increasing evidence indicates that poor control of blood glucose during 
surgery and in the perioperative period increases the risk of infection, and 
worsens  outcome  from  sepsis.  Diabetic  patients  have  a  higher  risk  of 
infection of both the sternal incision arid the vein harvest incisions on the 
lower extremities.   Tight control  of  blood glucose by the anesthesiologist 
during surgery must be accomplished to decrease the risk, and that control 
must  extend  into  the  immediate  postoperative  period  as  well.  Moderate 
hyperglycemia  (>200  mg/  dL)  at  any  time  on  the  first  postoperative  day 
increases  the  risk  of  surgical  site  infection  after  non-cardiac  surgery 
Hyperglycemia during the immediate phase of trauma resuscitation increases 
the risk of nosocomial infection and death after trauma. Exogenous insulin 
administration to  keep blood glucose concentrations of <120 mg/ dL was 
associated  with  a  40% decrease  of  mortality  among critically  ill  surgical 
patients with sepsis. The need to manage carbohydrate metabolism carefully 
has  important  implications  for  the  nutritional  management  of  surgical 
patients.
Gastrointestinal surgery may render the gastrointestinal tract unusable 
as a route of feeding, sometimes for prolonged periods. Ileus is common in 
surgical  Intensive  care  units  (ICUs),  whether  from traumatic  brain injury, 
narcotic  analgesia,  prolonged  bed  rest,  inflammation  in  proximity  to  the 
peritoneal  envelope  (lower  lobe  pneumonia,  retroperitoneal  hematoma, 
fractures  of  the  thoraco-Iumbar  spine,  pelvis,  or  hip),  or  other  causes. 
Parenteral nutrition is relied upon for feeding, despite evidence of a lack of 
efficacy and the possibility of hepatic dysfunction; hyperglycemia may be an 
important  complication  as  well.  Every  effort  should  be  made  to  provide 
enteral  feedings,  including  the  use  of  pro-motility  agents  such  as 
erythromycin.  Substantial evidence indicates that enteral feedings reduce the 
risk  of  nosocomial  infection  by  nearly  one  half  among  critically  ill  and 
injured patients.
CELLULAR, BIOCHEMICAL, CLINICAL & PATHOLOGICAL 
ASPECTS OF WOUND HEALING
Healing by first intention :
The  incision  causes  death  of  limited  number  of  epithelial  and 
connective tissues as well  as distrubtion of epithelial  basement membrane 
continuity.   The  narrow  incisional  space  immediately  fills  with  collotted 
blood contains firbrin and blood cells dehydration of the surface clot forms 
the well  known scap that  covers  the  wound.   The healthy  process follow 
services of sequential steps.
Within 24 hrs :
Neutrophic apex at the margins of the incision. Many towards the fibrin 
clot.  In 24 to 48 hrs spur of epithelial cells moves from wound edges along 
the cut margins of the dermis depositing basement membrane components as 
they move.   They fuse in the midline beneath the surface scab producing 
consunience but thin epithelial layer that closes the wound.
By day 3 :
The neurophils have been longer replaced by macrophages. Granulation 
tissue progressively invades the incision space.  Collagen fibres are point in 
the margin of the incision but at first they are vertically oriented and don’t 
bridge the incision. Epithelial cell proliferation thickens the epidermal layer.
By day 5 :
The  incisional  space  is  filled  with  granulation  tissue. 
Neovascularisation is maximal.  Collagen fibrils become more abundant and 
begin to bridge the incision.  The epidermis recovers its normal thickeness 
and differentiation  of  surface  cells  yields  a  mature  epidermal  architecture 
with surface keratinization.
2nd week :
There  is  continued  accumulation  of  collagen  and  proliferation  of 
fibroblasts.  The leukocytic infiltration, odema and increased vascularity have 
largely  disappeared.   At  this  time  the  long  process  of  bleaching  begins 
accomplished by the increased accumulates of collagen with in the incisional 
scar accomplished by regression of vascular channels. 
By the end of 1st month :
Scar is mode of a cellular connective tissue decend of inflammatory 
infiltration could now try intact epidermis.  The dermal appendages that a 
destroyed at the line of incision are permanently lost.  Tensile strength of the 
wound increase thereafter, but it may take months for the wounded area to 
obtain its maximal strength.
Healing try 2nd intention (wound with separated edges)
When there is more loss of cell and tissue as in surface wounds that 
create large defects the reparative process is more complicated.  Regeneration 
of parenchymal cells causing completely restore the original architecture and 
less abundant granulation tissue grows in from the margin to complete the 
repair.  This form of healing is referred to as secondary union or healing by 
second intention secondary healing differs from primary in several respects.
Inevitably large tissue defect generation a large fibrin clot that fills the 
defect  and  more  necrotic  debris  and  caudatic  that  must  be  removed. 
Consequently the inflammatory reaction is more intensive.
Much large amount of granulation tissue are found perhaps the feature 
that most clearly differentiate in the wound contracture which occur in large 
surface wounds. Initial step of wound contracture is formation of network of 
action containing fibroblasts at the edge of the wound.  Permanent wound 
contractive requires action of myofibroblasts altered fibroblasts that have the 
ultra structural character of smooth muscle cells.  Contraction of there cells at 
the wound edge decreases the gap between the dermal edges of the wound.  
Substantial scar formation and thinning of the epidermis.
Mechanisms of Wound Healing :
Wound  healing,  as  we  have  seen,  is  a  complex  (but  orderly) 
phenomenon  involving  a  number  of  processes,  including  induction  of  an 
acute inflammatory process by the wounding, regeneration of parenchymal 
cells, migration and proliferation of both parenchymal and connective tissue 
cells,  synthesis  of  Extra  cellular  matrix  (ECM)  proteins,  remodeling  of 
connective  tissue  and  parenchymal  components,  and  collagenization  and 
acquisition of wound strength.  As noted the deposition of connective tissue 
matrix, particularly collagen its remodeling into a scar and the acquisition of 
wound strength are the ultimate effects of orderly wound repair.  We shall 
end  this  discussion  of  wound healing  by  considering  the  determinants  of 
wound collagenization.
Collagen synthesis : Degradation and wound strength :
Collagen is the most common protein in the animal world, providing the 
extracellular frame work for all multicellular organisms.  Without collagen, a 
human being would be reduced to a clump of cells, interconnected by a few 
neurons.  The essential product of the fibroblast, collagen, ultimately 
provides  the  tensile  strength  of  healing  wounds.   On  the  basis  of  the 
biochemical composition of the chains that make up the triple helix of the 
collagen molecule, some 14 types of collagen can be discerned, of which the 
most well characterized.  Types I, II  and III are the interstitial or fibrillar 
collagens.  Types IV, V and VI are amorphous and are present in interstitial 
tissue and basement membranes.
Following synthesis on ribosomes, the alpha chains are subjected to a 
number of enzymatic modifications, including hydroxylation of praline in the 
alpha  position,  providing  collagen  with  its  characteristic  high  content  of 
hydroxyproline (about 10%).  This hydroxylation, which is dependent on the 
availability of ascorbic acid (vitamin C) is important because it is necessary 
to hold the three alpha chains together.
At this stage the precollagen molecule is still soluble and contains extra 
length of polypeptide and C terminal at the ends of the chain.  During or 
shortly after excretion from the cell, procollagen peptidases clip the terminal 
peptide  chains,  promoting  formation  of  fibrils.   True  fibrils  form in  the 
extracellular  space,  and  these  collagen  fibrils  give  strength  to  connective 
tissue.  A critical extracellular modification is lysyl hydroxylysyl oxidation, 
because  this  results  in  cross  linkages  between  alpha  chains  of  adjacent 
molecules  and  is  the  basis  of  the  structural  stability  of  collagen.   Cross 
linking is a major contributor to the tensile strength of collagen.
As previously described, collagen synthesis by fibroblasts begins early 
in wound healing, by day 3 or 5, and continues for several weeks, depending 
on wound size.  Collagen synthesis is stimulated by several factors, including 
growth factors (PDGF, FGF, TGF-beta) and cytokines (IL-1, IL-4), which are 
secreted  by  leukocytes  and  fibroblasts  in  healing  wounds.   Net  collagen 
accumulation, however depends not only on synthesis but also on collagen 
degradation.
Degradation of collagen and other Extra cellular matrix (ECM) proteins 
is achieved by a family of metalloproteinases, which are dependent on zinc 
ions for their activity.  (Neutorphil elastase, cathepsin G, kinins, plasmin, and 
other important proteolytic enzymes mentioned earlier can also degrade extra 
cellular  matrix  components,  but  they  are  serine  proteinaes,  not  metal 
loenzymes).   Metalloproteinases  consist  of  interstitial  collagenases,  which 
cleave  the  fibrillar  collagen  types  I,  II  and  III  ;  gelatinases  (or  type  IV 
collagenases) which degrade amorphous collagen as well as fibronectin and 
amorphous collagens.   These enzymes are  produced by several  cell  types 
(fibroblasts,  macrophages,  neutrophils,  synovial  cells  and  some  epithelial 
cells) and their secretion is induced by many stimuli including growth factors 
(PDGF,  FGF),  cytokines  (IL-1,  TNF-alpha)  and  phagocytic  stimuli. 
Collagenases cleave collagen under physiologic conditions, cutting the triple 
helix into two unequal fragments, which are then susceptible to digestion by 
other proteases.  This is potentially harmful to the organism, but the enzyme 
is  elaborated  in  a  latent  (procollagenase)  form  that  can  be  activated  by 
chemicals  (HOCI  produced,  as  you  recall,  during  the  oxidative  burst  of 
leukocytes) and proteases (plasmin).   Once formed, activated collagenases 
can  be  rapidly  inhibited  by  a  family  of  specific  tissue  inhibitors  of 
metalloproteinase (TIMP), which are produced by most mesenchymal cells. 
There  are  thus  multiple  checks  against  the  uncontrolled  action  of  these 
proteinases.  Nevertheless, it is thought that the collgenases play a role in 
degrading collagen in inflammation and wound healing.  Degradation aids in 
the debridement of injured sites and also in the remodeling of connective 
tissue necessary to repair the defect.  Indeed, collagenases and their inhibitors 
have been shown to be spatially and temporally regulated in healing burn 
wounds.
We now turn to the questions of how long it takes for a skin wound to 
achieve its maximal strength and which substances contribute to this strength. 
When  sutures  are  removed,  usually  at  the  end  of  the  first  week,  wound 
strength  is  approximately  10% of  the  strength  of  unwounded skin,  but  it 
increases rapidly over the next 4 weeks. This rate of increase then slows at 
approximately the third month after the original incision and then reaches a 
plateau at about 70 to 80% of the tensile strength of unwounded skin, which 
indeed may persist  for life.   The recovery of tensile  strength results  from 
increased collagen synthesis exceeding collagen degradation during the first 
2 months and from structural modifications of collagen fibers (cross-linking, 
increased fiber size), when collagen synthesis ceases at later times.
We can conclude this discussion of wound healing and collagenization 
by emphasizing that the healing wound, as a prototype of many other forms 
of tissue repair, is a dynamic and changing process.   The early phase is one 
of  inflammation,  followed  by  a  stage  of  fibroplasias,  followed  by  tissue 
remodeling and scaring.  Different mechanisms occurring at different times 
trigger the release of chemical signals that modulate the orderly migration, 
proliferation, and differentiation of cells and the synthesis and degradation of 
extra cellular matrix proteins.  These proteins, in turn, directly affect cellular 
events and modulate cell responsiveness to soluble growth factors.
The magic behind the seemingly precise orchestration of these events 
under normal conditions remains beyond our grasp, but almost certainly lies 
in  the  regulation  of  specific  soluble  mediators  and  their  receptors  on 
particular cells, cell-matrix interactions, and a controlling effect of physical 
factors, including forces generated by changes in cell shape and plasticity.
Pathologic aspects of inflammation and repair
The usual manifestations of inflammation and repair and we reviewed 
the orderly healing of wounds in normal persons.  But these processes are 
modified  by  a  number  of  known  influences  and  some  unknown  ones, 
frequently  impairing  the  quality  and  adequacy  of  both  inflammation  and 
repair.
Many systemic  and local  host  factors  influence the adequacy of  the 
inflammatory reparative response.  Nutrition has profound effects on wound 
healing.   Protein  deficiency,  for  example  and  particularly  vitamin  C 
deficiency,  inhibit  collagen  synthesis  and retard  healing.   Glucocorticoids 
have  well  documented  anti-inflammatory  effects  that  influence  various 
components of inflammation and fibroplasias.  Of the local factors, infection 
is the single most important cause of delay in healing.  Mechanical factors 
such  as  increased  abdominal  pressure  may  cause  rupture  of  abdominal 
wounds, called wound dehiscence.  Inadequate blood supply usually caused 
by arteriosclerosis or venous abnormalities that retard venous drainage also 
impair  healing.   Finally,  foreign  bodies  such  as  necessary  sutures  or 
fragments of steel, glasss or even bone constitute impediments to healing.
Aberrations of growth may occur even in what may begin initially as 
normal wound healing.  The accumulation of excessive amounts of collagen 
may give rise to a raised tumorous scar known as a keloid.  Keloid formation 
appears  to  be  an  individual  predisposition,  and  for  reasons  unknown this 
aberration is somewhat more common in blacks.  We still do not know the 
mechanisms of keloid formation.  Another deviation in wound healing is the 
formation of excessive amounts of granulation tissue, which protrudes above 
the level of the surrounding skin and in fact blocks re-epithelialization.  This 
has been called exuberant granulation or,  with more literary fervor,  proud 
flesh.   Excessive  granulations  must  be  removed  by  cautery  or  surgical 
excision to permit  restoration of the continuity of the epithelium.  Finally 
(fortunately rarely), incisional scars or traumatic injuries may be followed by 
exuberant proliferations of fibroblasts and other connective tissue elements 
that  may,  in  fact,  recur  after  excision.  Called  desmoids  or  aggressive 
fibromatoses,  these  lie  in  the  interface  between  benign  proliferations  and 
malignant (though low-grade) tumors.  Indeed, the line between the benign 
hyperplasias characteristic of repair and neoplasia is frequently finely drawn.
The  mechanism  underlying  the  fibroplasias  of  wound  repair  –  cell 
proliferations,  cell  –  cell  interactions,  cell-matrix  interactions,  and  ECM 
deposition  –  are  similar  to  those  that  occur  in  the  chronic  inflammatory 
fibrosis of such diseases as rheumatoid arthritis, lung fibrosis, and hepatic 
cirrhosis.   Unlike  orderly  wound  healing,  however,  the  diseases  are 
associated  with  persistence  of  initial  stimuli  for  fibroplasias  or  the 
development  of immune and autoimmune reactions in  which lymphocyte-
monocyte interactions sustain the synthesis and secretion of growth factors 
and fibrogenic cytokines, proteolytic enzymes and other biologically active 
molecules.  Collagen  degradation  by  collagenases,  for  example,  which  is 
important in the normal remodeling of healing wounds, causes much of the 
joint destruction in rheumatoid arthritis.
OBSERVATION AND RESULTS
During the study period of 2 years, 200 cases were observed of which 
100 elective cases and 100 emergency cases.
On 50 elective cases and emergency cases povidone iodine was used as 
skin antiseptic for various procedures. Likewise 4% Chlorhexidine gluconate 
was used as skin antiseptic on 50 elective cases and emergency cases for 
various procedures. 
On observing the patient in the immediate post operative period in the 
aspect of surgical site infection we got the following results.
In  patients  to whom we used Povidone iodine as  skin antiseptic  the 
following rate of SSI observed.
In Elective Cases
The rate of Superficial Surgical site infection - 20%
Deep Surgical site infection -  4%
In emergency cases
The rate of Superficial Surgical site infection - 26%
Deep Surgical site infection -  8%
In patients on whom we used 4% Chlorhexidine gluconate as skin antiseptic 
the following rate of SSI observed.
The rate of Superficial Surgical site infection - 10%
Deep Surgical site infection - 2 %
Emergency cases :
The rate of Superficial Surgical site infection - 16%
Deep Surgical site infection -  4%
From the above observation it shows that in case of elective procedures 
there  is  50%  reduction  of  superficial  Surgical  site  infection and  50% 
reduction  of  deep  Surgical  site  infection and  also  in  case  of  emergency 
procedures there was a 39% reduction of superficial  Surgical site infection 
and 50% reduction of Deep Surgical site infection.
DISCUSSION
Previous studies  showed that  Chlorhexidine gluconate is  effective in 
reducing bacterial counts on the skin.  Kaiser et al., found that Chlorhexidine 
gluconate was  more  effective  than  povidone-iodine  in  reducing  skin 
colonization  with  staphylococci  and  that  repeated  applications  of 
Chlorhexidine gluconate were superior to a single applications.  A fullbody 4 
percent  Chlorhexidine  gluconate shower  reduces  bacterial  counts  at 
abdominal  and inguinal  sites,  and a 4 percent  Chlorhexidine  gluconate two 
minute surgical scrub has been shown to reduce microbial counts better than 
povidone-iodine. 
 Recent data from DeBaun confirms a 99.9 percent reduction in MRSA 
after three minutes of exposure to Chlorhexidine gluconate and Acinetobacter 
after  15  seconds  of  exposure.   These  studies  show  the  effectiveness  of 
Chlorhexidine  gluconate in  reducing  bacterial  counts,  which  may,  in  turn, 
reduce surgical site infection rates.  Given today’s healthcare environment 
and patient concerns with Methicillin resistant S.aureus (MRSA), which they 
refer  to  as  ‘superbugs’,  it  seems  prudent  to  have  patients  apply  full-skin 
antisepsis before entering the operating room.
Although it would be expected that skin antisepsis would reduce SSI 
rates, studies of previously available skin antiseptics yielded mixed results.
Chlorhexidine  gluconate solution  reduced  surgical  site  infections 
compared with iodine-based products in one study, whereas four studies of 
iodine-based  preps  found  no  reduction  in  Surgical  site  infections.   These 
studies examined the benefits of using a 4 percent  Chlorhexidine gluconate 
solution.
Edmiston  et  al,  found  that  although  both  4  percent  Chlorhexidine 
gluconate solution  and  a  2  percent  Chlorhexidine  gluconate impregnated 
cloth were effective at reducing bacterial counts.  
During the study period of 2 years on patients in the aspect of SSI with 
the use of above mentioned methods strictly followed.  In case of superficial 
SSI in case of elective procedures there is 50% reduction and in case of Deep 
surgical site infection 50% reduction observed in elective cases and 39% in 
superficial  surgical  site  infection  and  50%  Deep  surgical  site  infection 
reduction in emergency cases.
The strength of this study were its prospective nature and that a 
large number of procedures were monitored. Because this was a pilot study 
and not a controlled study, further analysis of results and direct comparison 
with  another  product  was  not  done.  Also  the  lack  of  a  control  group 
prevented estimation of the relative benefits of avoiding hypothermia in the 
study group.
CONCLUSION
Surgical site infections are a serious medical problem associated with 
increased morbidity and mortality and increased medical  care costs.   This 
study showed that a new presurgical preparation protocol using warmed 4% 
Chlorhexidine gluconate skin antiseptic of surgical site infection compared 
with  a  historical  observation  period.   This  reduction  in  surgical  site 
infections, in turn, led to reduced medical costs, even when the cost of the 
Chlorhexidine gluconate was taken into account.  Because of these promising 
results, our facility has chosen to continue to use the 4 percent Chlorhexidine 
gluconate antiseptic as skin antiseptic.
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PROFORMA
Name   : Age  :
Sex : Inpatient No. :
Unit :
D.O.A : D.O.S :
Elective
Procedure
Emergency
Chlorhexidine 4%
Material
Povidone Iodine 7.5%
Method :
Microbiology result :
Follow up :
Outcome of the study :
Conclusion :







 



